BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30132842)

  • 21. Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Proliferation and Metastasis of Osteosarcoma Cells by Targeting c-Met and SOX4 via miR-34a/c-5p and miR-449a/b.
    Sun Z; Zhang T; Chen B
    Med Sci Monit; 2019 Feb; 25():1410-1422. PubMed ID: 30793707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma.
    Liu P; Yang H; Zhang J; Peng X; Lu Z; Tong W; Chen J
    Sci Rep; 2017 Jul; 7(1):5186. PubMed ID: 28701723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of MALAT1 and PVT1 Variants, Expression Profiles and Target miRNA-101 and miRNA-186 with Colorectal Cancer: Correlation with Epithelial-Mesenchymal Transition.
    Radwan AF; Shaker OG; El-Boghdady NA; Senousy MA
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MALAT1 promoted invasiveness of gastric adenocarcinoma.
    Lee NK; Lee JH; Ivan C; Ling H; Zhang X; Park CH; Calin GA; Lee SK
    BMC Cancer; 2017 Jan; 17(1):46. PubMed ID: 28077118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Noncoding RNA MALAT1 Contributes to Sorafenib Resistance by Targeting miR-140-5p/Aurora-A Signaling in Hepatocellular Carcinoma.
    Fan L; Huang X; Chen J; Zhang K; Gu YH; Sun J; Cui SY
    Mol Cancer Ther; 2020 May; 19(5):1197-1209. PubMed ID: 32220970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway.
    Jin Y; Feng SJ; Qiu S; Shao N; Zheng JH
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3176-3184. PubMed ID: 28770968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The long non-coding RNA MALAT1 promotes the migration and invasion of hepatocellular carcinoma by sponging miR-204 and releasing SIRT1.
    Hou Z; Xu X; Zhou L; Fu X; Tao S; Zhou J; Tan D; Liu S
    Tumour Biol; 2017 Jul; 39(7):1010428317718135. PubMed ID: 28720061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Chain Non-Coding RNA Metastasis-Related Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes the Proliferation and Migration of Human Pulmonary Artery Smooth Muscle Cells (hPASMCs) by Regulating the MicroRNA-503 (miR-503)/Toll-Like Receptor 4 (TLR4) Signal Axis.
    He M; Shen J; Zhang C; Chen Y; Wang W; Tao K
    Med Sci Monit; 2020 Jul; 26():e923123. PubMed ID: 32712618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma.
    Li Q; Zhang C; Chen R; Xiong H; Qiu F; Liu S; Zhang M; Wang F; Wang Y; Zhou X; Xiao G; Wang X; Jiang Q
    Cancer Lett; 2016 Dec; 383(1):28-40. PubMed ID: 27693631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b/STAT3 axis.
    Chang SM; Hu WW
    J Cell Physiol; 2018 Apr; 233(4):3384-3396. PubMed ID: 28926115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MALAT1-mediated tumorigenesis.
    Liu J; Peng WX; Mo YY; Luo D
    Front Biosci (Landmark Ed); 2017 Jan; 22(1):66-80. PubMed ID: 27814602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis.
    Yu F; Lu Z; Cai J; Huang K; Chen B; Li G; Dong P; Zheng J
    Cell Cycle; 2015; 14(24):3885-96. PubMed ID: 26697839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA-MALAT1/miRNA-204-5p/Smad4 Axis Regulates Epithelial-Mesenchymal Transition, Proliferation and Migration of Lens Epithelial Cells.
    Peng C; Wang Y; Ji L; Kuang L; Yu Z; Li H; Zhang J; Zhao J
    Curr Eye Res; 2021 Aug; 46(8):1137-1147. PubMed ID: 33327804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple function of lncRNA MALAT1 in cancer occurrence and progression.
    Malakoti F; Targhazeh N; Karimzadeh H; Mohammadi E; Asadi M; Asemi Z; Alemi F
    Chem Biol Drug Des; 2023 May; 101(5):1113-1137. PubMed ID: 34918470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MALAT1: A key regulator in lung cancer pathogenesis and therapeutic targeting.
    Bhat AA; Afzal O; Afzal M; Gupta G; Thapa R; Ali H; Hassan Almalki W; Kazmi I; Alzarea SI; Saleem S; Samuel VP; Gubbiyappa SK; Subramaniyan V
    Pathol Res Pract; 2024 Jan; 253():154991. PubMed ID: 38070223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastasis Associated Lung Adenocarcinoma Transcript 1: An update on expression pattern and functions in carcinogenesis.
    Ghafouri-Fard S; Ashrafi Hafez A; Taheri M
    Exp Mol Pathol; 2020 Feb; 112():104330. PubMed ID: 31712117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss.
    Arun G; Diermeier S; Akerman M; Chang KC; Wilkinson JE; Hearn S; Kim Y; MacLeod AR; Krainer AR; Norton L; Brogi E; Egeblad M; Spector DL
    Genes Dev; 2016 Jan; 30(1):34-51. PubMed ID: 26701265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer.
    Xu S; Sui S; Zhang J; Bai N; Shi Q; Zhang G; Gao S; You Z; Zhan C; Liu F; Pang D
    Int J Clin Exp Pathol; 2015; 8(5):4881-91. PubMed ID: 26191181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer.
    Wang SH; Zhang WJ; Wu XC; Weng MZ; Zhang MD; Cai Q; Zhou D; Wang JD; Quan ZW
    J Cell Mol Med; 2016 Dec; 20(12):2299-2308. PubMed ID: 27420766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGF-β-induced STAT3 overexpression promotes human head and neck squamous cell carcinoma invasion and metastasis through malat1/miR-30a interactions.
    Wang Y; Wu C; Zhang C; Li Z; Zhu T; Chen J; Ren Y; Wang X; Zhang L; Zhou X
    Cancer Lett; 2018 Nov; 436():52-62. PubMed ID: 30118844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.